SRPT

Sarepta Therapeutics, Inc.

1 day chart

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It develops therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. It commercializes three products, such as EXONDYS 51 (eteplirsen) Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53) and AMONDYS 45 (casimersen) Injection (AMONDYS 45). These commercial products are indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51, exon 53 and exon 45 skipping. Its pipeline includes approximately 40 programs at various stages of discovery, pre-clinical and clinical development.

Buy US stocks in Australia starting with SRPT. Open an account and start investing today!

Market Capitalisation

$7.90B

Price-earnings ratio

Dividend yield

0.00%

Volume

1.32M

High today

$84.50

Low today

$78.67

Open price

$81.28

52-week high

$159.89

52-week low

$55.25

SRPT FAQs

Can I buy SRPT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy SRPT shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Sarepta Therapeutics, Inc.?

One share of Sarepta Therapeutics, Inc. is valued at $84.23.

What is the ticker symbol for Sarepta Therapeutics, Inc.?

The ticker symbol for Sarepta Therapeutics, Inc. is SRPT.

How do I buy SRPT shares in Australia?

To buy SRPT stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in SRPT

What is the 52-week high for Sarepta Therapeutics, Inc. stock?

The Sarepta Therapeutics, Inc. 52-week high stock price is $159.89.

What is the 52-week low for Sarepta Therapeutics, Inc. stock?

The Sarepta Therapeutics, Inc. 52-week low stock price is $55.25.

What is the market capitalisation of Sarepta Therapeutics, Inc. SRPT?

As of 03/12/2023 Sarepta Therapeutics, Inc. has a market cap of $7.9B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.